S

Sandra M. Swain

Georgetown University

ORCID: 0000-0002-1320-3830

Publishes on Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology. 559 papers and 52.6k citations.

PubIndex Score98Top 2%How it's scored

559Publications

52.6kTotal Citations

First publication: 1980First senior author: 1980

Breast Cancer Treatment Studies HER2/EGFR in Cancer Research Cancer Treatment and Pharmacology Advanced Breast Cancer Therapies Estrogen and related hormone effects

Top publicationsby citations

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

Patricia Cortazar, Gϋnter von Minckwitz, Lijun Zhang et al.|The Lancet|2014

Cited by 4.7k

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

Fátima Cardoso, Eric P. Winer, Prudence A. Francis et al.|Annals of Oncology|2016

Cited by 2.1k

Targeting HER2-positive breast cancer: advances and future directions

Sandra M. Swain, Erika Hamilton|Nature Reviews Drug Discovery|2022

Cited by 1k

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Sibylle Loibl, Nadia Harbeck, Fabrice André et al.|Annals of Oncology|2023

Cited by 830

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

Sandra M. Swain, Richard A. Gams, Fredrick S. Whaley et al.|Journal of Clinical Oncology|1997

Cited by 652